Glycopyrrolate and Formoterol and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Glycopyrrolate and Formoterol and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: formoterol / glycopyrrolate
Brand name: Bevespi Aerosphere
Synonyms: Formoterol and glycopyrrolate
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycopyrrolate and Formoterol-Moxifloxacin
- Glycopyrrolate and Formoterol-Moxifloxacin (Systemic)
- Glycopyrrolate and Formoterol-Moxifloxacin Hydrochloride
- Glycopyrrolate and Formoterol-Moxifloxacin Injection
- Glycopyrrolate and Formoterol-Moxifloxacin Intravenous
- Glycopyrrolate and Formoterol-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate and formoterol Inhalation
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate and indacaterol inhalation
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Capsules for Inhalation
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate inhalation
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Inhalation Solution
- Moxetumomab pasudotox-tdfk Intravenous-Glycopyrrolate Injection